Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors: Wang L, Ellsworth KA, Moon I, et al (Mayo Clinic, Rochester, MN; et al) Cancer Res 70:319-328, 2010§